National Law Journal | Analysis
By Amanda Bronstad | October 23, 2018
A significant opinion by the U.S. Court of Appeals for the First Circuit is expected to bolster the defense argument that judges shouldn't grant certification of class actions with uninjured class members. Judge William Kayatta wrote on Oct. 15 that a judge should not have granted certification of an antitrust class in which 10 percent of the class members had no injuries.
By Amanda Bronstad | September 13, 2018
On Thursday, Merck urged the Supreme Court to clarify its "clear evidence" holding in Wyeth v. Levine and reverse a 2017 decision that reinstated more than 500 cases over its osteoporosis drug Fosamax.
By Scott Graham | September 13, 2018
Valeant's attempt to disqualify a team of Katten Muchin Rosenman patent litigators led to a showdown Wednesday at the Federal Circuit.
By Amanda Bronstad | September 12, 2018
After kicking off with two verdicts awarding over $140 million, the docket of more than 6,000 cases alleging "low testosterone" treatments caused heart attacks and bloodclots comes to an end in a global settlement.
By Amanda Bronstad | August 30, 2018
A judge has allowed the state of Ohio's case to go forward against several opioid manufacturers in a ruling that plaintiffs lawyers are citing in…
By Amanda Bronstad | August 28, 2018
The case is one of at least six that Public Justice, a national nonprofit legal advocacy organization, has brought on behalf of consumers of eye drops.
By Amanda Bronstad | August 24, 2018
Lawyers attempting to negotiate a global settlement of lawsuits brought over the opioid epidemic aren't representing a key group: babies who have been born addicted to prescription painkillers.
By Amanda Bronstad | August 15, 2018
Opioid manufacturers and one distributor say the complaint against them lacks specifics to back up deceptive trade practices and public nuisance claims. But the amicus briefs said none of that mattered because a state has a “unique role” in the opioid crisis.
By Mike Scarcella | August 9, 2018
The U.S. Department of Justice had supported the former Allergan sales representative in the trial court but switched its stance in the U.S. Court of Appeals for the Second Circuit. The question presented to the court was one of first impression.
By Scott Graham | July 23, 2018
Judge Kimberly Moore's decision ends—at least for now—Allergan's arrangement to shield its patents using the Saint Regis Mohawk Tribe's immunity.
Presented by BigVoodoo
The National Law Journal honors attorneys & judges who've made a remarkable difference in the legal profession in the D.C. area.
New Jersey Law Journal honors lawyers leaving a mark on the legal community in New Jersey with their dedication to the profession.
This event shines a spotlight on the individuals, teams, projects and organizations that are changing the financial industry.
With bold growth in recent years, Fox Rothschild brings together 1,000 attorneys coast to coast. We offer the reach and resources of a natio...
About Us:Monjur.com is a leading provider of contracts-as-a-service for managed service providers, offering tailored solutions to streamline...
Dynamic Boutique law firm with offices in NYC, Westchester County and Dutchess County, is seeking a mid level litigation associate to work ...